4DMT is a clinical stage biopharma company inventing and developing innovative products to unlock the full potential of genetic medicine to treat large market and rare diseases. Our vector discovery platform Therapeutic Vector Evolution harnesses the power of directed evolution, a Nobel Prize-winning technology, with approximately one billion synthetic AAV capsid-derived sequences to invent customized and evolved vectors with improved therapeutic profiles compared to wild-type vectors. Our product design, development and manufacturing engine empowers us to efficiently create our valuable and diverse product pipeline. This combination of bold innovation and relentless execution gives 4DMT the capability to revolutionize genetic medicines and to strive for potential curative therapies. We have built a deep portfolio of genetic medicine product candidates, with five product candidates in clinical trials for seven patient populations. We are taking genetic medicine to new heights and into new disease areas to overcome challenges not addressed by existing medicines. This incredible challenge drives our relentless and talented team. Our people are the essence of our inspiring, innovative and collaborative environment that encourages individual contributions and provides opportunities for career development. We seek the best in the industry who identify with our mission and our bold and innovative results-driven approach. Our 4 Guiding Principles drive the way we work together: - Dare to Cure - Break Boundaries - Beyond Yourself - Prepare & Executive Relentlessly Join us in creating the future of genetic medicine.
View Top Employees from 4D Molecular TherapeuticsWebsite | http://www.4dmoleculartherapeutics.com/ |
Ticker | FDMT |
Revenue | $6 million |
Funding | $458 million |
Employees | 174 (169 on RocketReach) |
Founded | 2013 |
Address | 5858 Horton St 455, Emeryville, California 94608, US |
Phone | (510) 505-2680 |
Technologies |
JavaScript,
HTML,
Twitter
+57 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Therapeutic Devices, Gene Therapy, Business Services, Science and Engineering, Drug Discovery, Adeno-Associated Virus, Genetics, Health Care |
Web Rank | 2 Million |
Keywords | Genetic Testing |
Competitors | Asklepios BioPharmaceutical, Inc. (AskBio), MeiraGTx, Orchard Therapeutics, REGENXBIO Inc., Voyager Therapeutics, Inc. |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular 4D Molecular Therapeutics employee's phone or email?
The 4D Molecular Therapeutics annual revenue was $6 million in 2024.
Matthew Park is the Vice President Information Technology of 4D Molecular Therapeutics.
169 people are employed at 4D Molecular Therapeutics.
4D Molecular Therapeutics is based in Emeryville, California.
The NAICS codes for 4D Molecular Therapeutics are [54, 541, 5417].
The SIC codes for 4D Molecular Therapeutics are [87, 873].